LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

LLY

1,053.95

+4.48%↑

JNJ

245.58

+1.27%↑

ABBV

229.45

+2.09%↑

NVS

164.49

+1.11%↑

MRK

123.71

+1.19%↑

Search

Smith & Nephew PLC ADR

Geschlossen

36.05 -0.14

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

35.79

Max

36.23

Schlüsselkennzahlen

By Trading Economics

Einkommen

296M

Verkäufe

3B

KGV

Branchendurchschnitt

32.595

110.024

Dividendenrendite

2.11

Gewinnspanne

9.895

Angestellte

17,000

EBITDA

723M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

-4.62% downside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.11%

2.26%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

15B

Vorheriger Eröffnungskurs

36.19

Vorheriger Schlusskurs

36.05

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Smith & Nephew PLC ADR Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Feb. 2026, 23:55 UTC

Market Talk

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22. Feb. 2026, 23:53 UTC

Market Talk

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22. Feb. 2026, 23:53 UTC

Market Talk

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22. Feb. 2026, 23:51 UTC

Market Talk

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22. Feb. 2026, 23:35 UTC

Market Talk

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22. Feb. 2026, 23:21 UTC

Ergebnisse

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22. Feb. 2026, 23:20 UTC

Ergebnisse

Nickel Industries 2025 Operating Profit US$126.4 Million

22. Feb. 2026, 23:19 UTC

Ergebnisse

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22. Feb. 2026, 23:19 UTC

Ergebnisse

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22. Feb. 2026, 23:18 UTC

Ergebnisse

Nickel Industries Won't Pay a Final Dividend

22. Feb. 2026, 23:16 UTC

Ergebnisse

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22. Feb. 2026, 21:35 UTC

Ergebnisse

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22. Feb. 2026, 21:34 UTC

Ergebnisse

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22. Feb. 2026, 21:34 UTC

Ergebnisse

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22. Feb. 2026, 21:33 UTC

Ergebnisse

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22. Feb. 2026, 21:33 UTC

Ergebnisse

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol Final Dividend A$0.60/Share

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol FY Revenue A$31.37 Billion, Down 10%

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21. Feb. 2026, 14:31 UTC

Akquisitionen, Fusionen, Übernahmen

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21. Feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

20. Feb. 2026, 23:12 UTC

Akquisitionen, Fusionen, Übernahmen

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20. Feb. 2026, 22:12 UTC

Ergebnisse

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20. Feb. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20. Feb. 2026, 21:23 UTC

Ergebnisse

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20. Feb. 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20. Feb. 2026, 21:01 UTC

Akquisitionen, Fusionen, Übernahmen

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20. Feb. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Peer-Vergleich

Kursveränderung

Smith & Nephew PLC ADR Prognose

Kursziel

By TipRanks

-4.62% Nachteil

12-Monats-Prognose

Durchschnitt 34.46 USD  -4.62%

Hoch 34.91 USD

Tief 34 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Smith & Nephew PLC ADR – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

2 ratings

0

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

26.64 / 28.37Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat